Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001808317-26-000001

Director acquired 35,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wolf Myles · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-17 Grant or award : show line 1 in the form +35,700 169,081 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-17 Grant or award : show line 2 in the form Stock Option (Right to buy) +53,600 53,600 D
Loading xslF345X06/primarydocument.xml…